Efficacy and Safety of Tildrakizumab 100 Mg for Plaque Psoriasis in Patients Randomized to Treatment Continuation vs Treatment Withdrawal with Retreatment upon Relapse in Resurface 1. J of Skin [Internet]. 2020 Sep. 2 [cited 2026 May 1];4(5):s40. Available from: https://skin.dermsquared.com/skin/article/view/989